We serve Chemical Name:(4-AMINOPYRIDIN-3-YL)ACETICACID CAS:1227570-90-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(4-AMINOPYRIDIN-3-YL)ACETICACID
CAS.NO:1227570-90-2
Synonyms:(4-Amino-3-pyridinyl)acetic acid;3-Pyridineacetic acid, 4-amino-;(4-Aminopyridin-3-yl)acetic acid;2-(4-aminopyridin-3-yl)acetic acid;(4-AMINOPYRIDIN-3-YL)ACETICACID
Molecular Formula:C7H8N2O2
Molecular Weight:152.151
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:428.4±30.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.624
PSA:76.94000
Exact Mass:152.058578
LogP:-0.45
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (4-Amino-3-pyridinyl)acetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(4-AMINOPYRIDIN-3-YL)ACETICACID physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(4-Aminopyridin-3-yl)acetic acid Use and application,3-Pyridineacetic acid, 4-amino- technical grade,usp/ep/jp grade.
Related News: In Massachusetts, where the bulk of Takeda’s U.S. operations are based since the Shire buyout, the Japanese pharma has been swiftly ramping up its cell therapy ambitions. In September, the company cut the ribbon on a new 24,000-square-foot R&D manufacturing center in Boston, which it said at the time would handle clinical development for three ongoing pipeline programs and two other prospects pegged to enter clinical development by the end of 2021. 1-(4-(4-((2R,4S)-2-benzyl-1-(3,5-bis(trifluoromethyl)benzoyl)piperidin-4-yl)piperazin-1-yl)piperidin-1-yl)-2-methylpropan-1-one manufacturers For category of products which involve fermentation technologies, incentive is 20 per cent of the approved sales price. The government has put a cap of Rs. 10 crore per product per annum for five years. This is a seven year scheme from 2023-24 going up to 2029-30. o-(3-Aethoxyheptyl)-anisol suppliers Charles River looks forward to continuing its ongoing partnership with AstraZeneca. It was great to join the team today, to see the facility for myself and congratulate them on this really significant expansion, which will see an €8m investment, creating 90 new jobs for Mayo. 3-(3-chloro-4-methyl-phenyl)-2-methyl-3H-quinazolin-4-one vendor & factory.
